Results 131 to 140 of about 3,505 (170)

Botulinum Toxin for Neurogenic Detrusor Overactivity

2011
Patients with neurogenic bladder dysfunction suffer from detrusor overactivity (detrusor hyperreflexia), which may be combined with detrusor sphincter dyssynergia (DSD; uncoordinated voiding). Both conditions cause high intravesical pressure and can lead to upper urinary tract damage.
Michael B. Chancellor, Christopher P. Smith   +1 more
openaire   +1 more source

Urethral Sphincter EMG as Event Detector for Neurogenic Detrusor Overactivity

IEEE Transactions on Biomedical Engineering, 2007
The aim of this study was to investigate the feasibility of using external urethral sphincter electromyogram (EMG) (EUSEMG) to detect the onset of detrusor contractions in patients with both neurogenic detrusor overactivity (NDO) and detrusor sphincter dyssynergia (DSD).
John Hansen, Albert Borau, Alfred Rodriguez, Joan Vidal, Thomas Sinkjær, Nico J. M. Rijkhoff   +5 more
openaire   +2 more sources

Refractory neurogenic detrusor overactivity.

International journal of clinical practice. Supplement, 2007
Refractory neurogenic detrusor overactivity refers to the clinical condition that is no longer manageable by anticholinergic therapy. This condition represents a formidable task to caregivers because the treatment of urinary incontinence and adequate protection of the upper urinary tract become extremely difficult.
F, Cruz, C, Silva
openaire   +1 more source

Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder

Neurourology and Urodynamics, 2014
Overactive bladder (OAB) is a symptom syndrome consisting of urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence (UUI), in the absence of a causative infection or pathological conditions. The prevalence of OAB is approximately 11–19% in both men and women, and leads to a significant negative ...
openaire   +2 more sources

Incontinence Due to Neurogenic Detrusor Overactivity

2017
Incontinence due to neurogenic detrusor overactivity (NDO) is often the most bothersome symptom that significantly decreases patients’ quality of life. It typically occurs when neurological lesions affect suprapontine and/or suprasacral pathways regulating functions of the bladder.
Jacques Corcos, Mikolaj Przydacz
openaire   +1 more source

Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity

European Journal of Neurology, 2011
Background:  Although botulinum toxin (BoNT/A) injected into the detrusor muscle improves overactive bladder symptoms in patients with neurogenic detrusor overactivity, how it does so remains unclear. In this study, we investigated whether BoNT/A improves detrusor overactivity by modulating bladder afferent activity.Methods:  To do so, during ...
CONTE, ANTONELLA, A. Giannantoni, S. Proietti, S. Giovannozzi, FABBRINI, Giovanni, A. Rossi, M. Porena, BERARDELLI, Alfredo   +7 more
openaire   +5 more sources

Efficacy and Safety of Tol Terodine in People With Neurogenic Detrusor Overactivity

The Journal of Spinal Cord Medicine, 2004
To compare tolterodine with oxybutynin and placebo in people with neurogenic detrusor overactivity.Prospective, randomized, double-blind, crossover trial plus open-label comparative stage.Ten participants with neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis who used intermittent catheterization.Bladder capacity on ...
Karen D, Ethans, Patricia W, Nance, Robert J, Bard, Alan R, Casey, Orpha I, Schryvers   +4 more
openaire   +2 more sources

New therapeutic options for refractory neurogenic detrusor overactivity.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2004
Current pharmacologic treatment of detrusor overactivity relies on anticholinergic drugs. However, they often have untolerable side effects so that they are administered in doses insufficient to restore urinary continence. Recently, intravesical instillations and injections into the detrusor muscle of new pharmacological agents have been developed. The
GIANNANTONI, Antonella, MEARINI, Ettore, Di Stasi, Savino Mauro, COSTANTINI, Elisabetta, ZUCCHI, ALESSANDRO, MEARINI, Luigi, FORNETTI, Pierfrancesco, DEL ZINGARO, Michele, Navarra, Pierluigi, PORENA, Massimo   +9 more
openaire   +4 more sources

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of “Overactive bladder”

Neurourology and Urodynamics, 2014
It is now clearly recognized that the function of the lower urinary tract represents a complex interaction between the bladder and its outlet, acting under the control of the central nervous system. While in the past attention has principally focused on the motor (efferent) control of the bladder, sensory (afferent) innervation is now known to be an ...
openaire   +2 more sources

Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity

Actas Urológicas Españolas (English Edition)
A Consensus document on the management of patients with neurogenic detrusor overactivity (NDO) was published in 2018. The present document aims to update its recommendations regarding treatment considering the new evidence available, and to contribute to the standardization of the management of this disorder.The methodology used was based on a ...
Borau, A., Salinas, J., Allue, M., Castro-Diaz, D., Esteban, M., Arlandis, S., Virseda, M., Adot, J. M.   +7 more
openaire   +3 more sources